Dr Samsuddin Khan performs physical exam of Deepak Sabhash Shegar, a person living with DR-TB, at MSF DR-TB clinic, Chembur, Mumbai, India, 2022
Letter |

Open Letter: Urgent action necessary for equitable access to bedaquiline in all countries with high burdens of TB, MDR-TB, and TB/HIV

INTELLECTUAL PROPERTY AND TRADE TUBERCULOSIS
TB_CSO-letter_Bdq-JNJ-2ndary-patent_20230711
Photo credit: Prem Hessenkamp

MSF Access Campaign, with other civil society organisations, signed onto this letter to Johnson & Johnson, calling on the pharmaceutical corporation not to enforce its secondary patents on the lifesaving TB drug bedaquiline.

 

Open Letter: Urgent action necessary for equitable access to bedaquiline in all countries with high burdens of TB, MDR-TB, and TB/HIV